Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

NCCN Guidelines Insights: Antiemesis, Version 2.2017.

Berger MJ, Ettinger DS, Aston J, Barbour S, Bergsbaken J, Bierman PJ, Brandt D, Dolan DE, Ellis G, Kim EJ, Kirkegaard S, Kloth DD, Lagman R, Lim D, Loprinzi C, Ma CX, Maurer V, Michaud LB, Nabell LM, Noonan K, Roeland E, Rugo HS, Schwartzberg LS, Scullion B, Timoney J, Todaro B, Urba SG, Shead DA, Hughes M.

J Natl Compr Canc Netw. 2017 Jul;15(7):883-893. doi: 10.6004/jnccn.2017.0117.

PMID:
28687576
2.

Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting.

DeRemer DL, Clemmons AB, Orr J, Clark SM, Gandhi AS.

Pharmacotherapy. 2016 Feb;36(2):218-29. doi: 10.1002/phar.1703. Review.

PMID:
26890915
3.

[Medical treatment of chemotherapy-induced nausea and vomiting].

Herrstedt J.

Ugeskr Laeger. 2007 Feb 26;169(9):799-805. Review. Danish.

PMID:
17355844
4.

Antiemesis clinical practice guidelines in oncology.

Ettinger DS, Bierman PJ, Bradbury B, Ellis G, Ignoffo RJ, Kirkegaard S, Kloth D, Krauss A, Kris MG, Lim D, Markiewicz MA, McNulty R, Noonan K, Stucky-Marshall L, Todaro B, Urba S, Yowell S; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2004 Sep;2(5):470-90. No abstract available.

PMID:
19780255
5.

Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies.

Feyer P, Seegenschmiedt MH, Steingraeber M.

Support Care Cancer. 2005 Sep;13(9):671-8. Epub 2005 Jul 26. Review.

PMID:
16044252
6.

Overview: oral granisetron (Kytril tablets) prophylaxis for chemotherapy-induced nausea and vomiting.

Perez EA.

Semin Oncol. 1995 Aug;22(4 Suppl 10):1-2. No abstract available.

PMID:
7570049
7.

[Prophylaxis of chemotherapy-induced vomiting and nausea].

Tóth J, Szántó J.

Magy Onkol. 2008 Dec;52(4):391-4. doi: 10.1556/MOnkol.52.2008.4.9. Review. Hungarian.

PMID:
19068468
8.

Olanzapine for preventing nausea and vomiting induced by moderately and highly emetogenic chemotherapy.

Wang SY, Yang ZJ, Zhang L.

Asian Pac J Cancer Prev. 2014;15(22):9587-92. Review.

9.

5HT3-receptor antagonists as antiemetics in cancer.

[No authors listed]

Drug Ther Bull. 2005 Aug;43(8):57-62.

PMID:
16111085
10.
11.

Effectiveness of serotonin-receptor antagonist antiemetic therapy over successive courses of carboplatin-based chemotherapy.

Markman MR, Peterson G, Kulp B, Markman M.

Gynecol Oncol. 2002 Jun;85(3):435-7.

PMID:
12051870
12.

A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.

Hsu ES.

Am J Ther. 2010 Sep-Oct;17(5):476-86. doi: 10.1097/MJT.0b013e3181ea7821. Review.

PMID:
20844345
13.

Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy.

Hesketh P.

Semin Oncol. 1995 Aug;22(4 Suppl 10):19-23. Review. No abstract available.

PMID:
7570050
14.

NCCN antiemesis guidelines emphasize 'delayed' emesis, new 5-HT3 inhibitors, and NK-1 blockers.

National Comprehensive Cancer Network (NCCN).

J Support Oncol. 2004 Jul-Aug;2(4):366. No abstract available.

PMID:
15357520
15.

First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.

Goldsmith B.

Acta Oncol. 2004 Sep;43 Suppl 15:19-22. Review. No abstract available.

PMID:
15370626
16.

Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults.

Sutherland A, Naessens K, Plugge E, Ware L, Head K, Burton MJ, Wee B.

Cochrane Database Syst Rev. 2018 Sep 21;9:CD012555. doi: 10.1002/14651858.CD012555.pub2. Review.

PMID:
30246876
17.

Effect of granisetron on performance status during high-dose interferon therapy.

Drapkin R, Barolo JL, Blower PR.

Oncology. 1999 Nov;57(4):303-5.

PMID:
10575316
18.

Slow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteria.

Raftopoulos H, Boccia R, Cooper W, O'Boyle E, Gralla RJ.

Future Oncol. 2015 Sep;11(18):2541-51. doi: 10.2217/fon.15.185. Epub 2015 Aug 20.

PMID:
26289588
19.

Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting.

Tan L, Liu J, Liu X, Chen J, Yan Z, Yang H, Zhang D.

J Exp Clin Cancer Res. 2009 Sep 23;28:131. doi: 10.1186/1756-9966-28-131.

20.

[Chemotherapy-induced emesis and serotonin antagonists].

Jantunen I, Johansson R.

Duodecim. 1991;107(14):1112-5. Review. Finnish. No abstract available.

PMID:
1670506

Supplemental Content

Support Center